Search Results - "Atherosclerosis"

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk by Mach, François, Baigent, Colin, Catapano, Alberico L., Koskinas, Konstantinos C., Casula, Manuela, Badimon, Lina, Chapman, M. John, De Backer, Guy G., Delgado, Victoria, Ference, Brian A., Graham, Ian M., Halliday, Alison, Landmesser, Ulf, Mihaylova, Borislava, Pedersen, Terje R., Riccardi, Gabriele, Richter, Dimitrios J., Sabatine, Marc S., Taskinen, Marja-Riitta, Tokgozoglu, Lale, Wiklund, Olov, Windecker, Stephan, Aboyans, Victor, Baigent, Colin, Collet, Jean-Philippe, Dean, Veronica, Delgado, Victoria, Fitzsimons, Donna, Gale, Chris P., Grobbee, Diederick, Halvorsen, Sigrun, Hindricks, Gerhard, Iung, Bernard, Jüni, Peter, Katus, Hugo A., Landmesser, Ulf, Leclercq, Christophe, Lettino, Maddalena, Lewis, Basil S., Merkely, Bela, Mueller, Christian, Petersen, Steffen, Petronio, Anna Sonia, Richter, Dimitrios J., Roffi, Marco, Shlyakhto, Evgeny, Simpson, Iain A., Sousa-Uva, Miguel, Touyz, Rhian M., Nibouche, Djamaleddine, Zelveian, Parounak H., Siostrzonek, Peter, Najafov, Ruslan, van de Borne, Philippe, Pojskic, Belma, Postadzhiyan, Arman, Kypris, Lambros, Špinar, Jindřich, Larsen, Mogens Lytken, Eldin, Hesham Salah, Viigimaa, Margus, Strandberg, Timo E., Ferrières, Jean, Agladze, Rusudan, Laufs, Ulrich, Rallidis, Loukianos, Bajnok, László, Gudjónsson, Thorbjörn, Maher, Vincent, Henkin, Yaakov, Gulizia, Michele Massimo, Mussagaliyeva, Aisulu, Bajraktari, Gani, Kerimkulova, Alina, Latkovskis, Gustavs, Hamoui, Omar, Slapikas, Rimvydas, Visser, Laurent, Dingli, Philip, Ivanov, Victoria, Boskovic, Aneta, Nazzi, Mbarek, Visseren, Frank, Mitevska, Irena, Retterstøl, Kjetil, Jankowski, Piotr, Fontes-Carvalho, Ricardo, Gaita, Dan, Ezhov, Marat, Foscoli, Marina, Giga, Vojislav, Pella, Daniel, Fras, Zlatko, Perez de Isla, Leopoldo, Hagström, Emil, Lehmann, Roger, Abid, Leila, Ozdogan, Oner, Mitchenko, Olena, Patel, Riyaz S.

Get full text

Dietary linoleic acid and human health: Focus on cardiovascular and cardiometabolic effects by Marangoni, Franca, Agostoni, Carlo, Borghi, Claudio, Catapano, Alberico L., Cena, Hellas, Ghiselli, Andrea, La Vecchia, Carlo, Lercker, Giovanni, Manzato, Enzo, Pirillo, Angela, Riccardi, Gabriele, Risé, Patrizia, Visioli, Francesco, Poli, Andrea

“…This narrative review aims to discuss the more relevant evidence on the role of linoleic acid (LA), a n-6 essential fatty acid that constitutes the predominant…”
Get full text

Endothelial dysfunction in COVID-19: Current findings and therapeutic implications by Nägele, Matthias P., Haubner, Bernhard, Tanner, Felix C., Ruschitzka, Frank, Flammer, Andreas J.

“…Coronavirus disease 2019 (COVID-19) increases the risk of several non-pulmonary complications such as acute myocardial injury, renal failure or thromboembolic…”
Get full text

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR) by Catapano, Alberico L, Graham, Ian, De Backer, Guy, Wiklund, Olov, Chapman, M John, Drexel, Heinz, Hoes, Arno W, Jennings, Catriona S, Landmesser, Ulf, Pedersen, Terje R, Reiner, Željko, Riccardi, Gabriele, Taskinen, Marja-Riita, Tokgozoglu, Lale, Verschuren, W M Monique, Vlachopoulos, Charalambos, Wood, David A, Zamorano, Jose Luis

Get full text

Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions by Raggi, Paolo, Genest, Jacques, Giles, Jon T., Rayner, Katey J., Dwivedi, Girish, Beanlands, Robert S., Gupta, Milan

“…Rudolph Virchow (1821–1902) recognized inflammation in histological preparations of coronary arteries and proposed that inflammation plays a causal role in…”
Get full text

Update on peripheral artery disease: Epidemiology and evidence-based facts by Shu, Jun, Santulli, Gaetano

Get full text

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries by Jankowski, Piotr, Reiner, Željko, De Backer, G., Abreu, A., Bruthans, J., Cifkova, R., Dilic, M., Dolzhenko, M., Lovic, D., Reiner, Ž., Rydén, L., Tsioufis, K., Jennings, C., Adamska, S., Willems, A.M., Dilic, M., Kapidjic, S., Zvizdic, F., Djekic, D., Terziev, A., Angelov, A., Glavina, M., Batinic, T., Sikic, J., Šulc, P., Ibrahim, A., Elsharef, M.A., Kholef, E.F., Haupt, A., Ludwig, K., Geisler, T., O'Donnell, M., Mariottoni, B., Aigerim, K., Kodasbayev, A., Asanbaev, A., Esenbekova, J., Asanbaev, A., Erglis, A., Kucika, G., Dzerve, V., Gedvilaite, L., Pečiuraite, D., Jankowski, P., Wiśniewski, A., Raczkowski, A., Szpakowicz, M., Haberka, M., Botelho, A., Cachulo, M., Daniel, P., Gaita, D., Gaita, L., Giurgiu, L., Hudrea, C., Moldovan, B., Borisova, L., Lalic, N.M., Macesic, M., Vukovic, A., Jug, B., Mogollón Jiménez, M.V., Perez Espejo, P., Botas, J., Campuzano, R., Irazusta, F.J., Vindel, C., Gómez-Doblas, J.J., García Ruíz, V., Molina Ramos, A., Marzal, D., Peters, R.J.G., Ç Erol, Ergene, O., Çırgamış, D., Akkoyun H Kültürsay, S., Tokgözoğlu, L., Koçyiğit, D., Temizhan, A., Ünal, S., İ Yakut, Konoplianyk, L., Nudchenko, O., Potabashny, V., Kosova, H., Hoye P Atkin, A., Lindsay, S., Bennett, C., Mills, C., Oustance, N., Yare, M., Bowyer, H., Gorog, D., De Sousa, P., Mazenenga, T., McKie, H., Wright, J., Wren, L., Sawyer, J., McGill, Y.

“…One of the objectives of the ESC-EORP EUROASPIRE V survey is to determine how well European guidelines on the management of dyslipidaemias are implemented in…”
Get full text

Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study by Ballantyne, Christie M., Banach, Maciej, Mancini, G.B. John, Lepor, Norman E., Hanselman, Jeffrey C., Zhao, Xin, Leiter, Lawrence A.

“…Patients with hyperlipidemia who are unable to tolerate optimal statin therapy are at increased cardiovascular risk due to ongoing elevations in low-density…”
Get full text

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) by Piepoli, Massimo F, Hoes, Arno W, Agewall, Stefan, Albus, Christian, Brotons, Carlos, Catapano, Alberico L, Cooney, Marie-Therese, Corrà, Ugo, Cosyns, Bernard, Deaton, Christi, Graham, Ian, Hall, Michael Stephen, Hobbs, F D Richard, Løchen, Maja-Lisa, Löllgen, Herbert, Marques-Vidal, Pedro, Perk, Joep, Prescott, Eva, Redon, Josep, Richter, Dimitrios J, Sattar, Naveed, Smulders, Yvo, Tiberi, Monica, Bart van der Worp, H, van Dis, Ineke, Verschuren, W M Monique

Get full text

The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society by Vlachopoulos, Charalambos, Xaplanteris, Panagiotis, Aboyans, Victor, Brodmann, Marianne, Cífková, Renata, Cosentino, Francesco, De Carlo, Marco, Gallino, Augusto, Landmesser, Ulf, Laurent, Stéphane, Lekakis, John, Mikhailidis, Dimitri P, Naka, Katerina K, Protogerou, Athanasios D, Rizzoni, Damiano, Schmidt-Trucksäss, Arno, Van Bortel, Luc, Weber, Thomas, Yamashina, Akira, Zimlichman, Reuven, Boutouyrie, Pierre, Cockcroft, John, O'Rourke, Michael, Park, Jeong Bae, Schillaci, Giuseppe, Sillesen, Henrik, Townsend, Raymond R

“…While risk scores are invaluable tools for adapted preventive strategies, a significant gap exists between predicted and actual event rates. Additional tools…”
Get full text

Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis by Li, Yunwei, Zhong, Xiaoming, Cheng, Guanchang, Zhao, Cuihua, Zhang, Lei, Hong, Yan, Wan, Qilin, He, Ruili, Wang, Zhizhong

“…Abstract Background and aims Inconsistent findings have been reported on the association between high-sensitivity C-reactive protein (hs-CRP) and mortality…”
Get full text

HEART UK consensus statement on Lipoprotein(a): A call to action by Cegla, Jaimini, Neely, R.Dermot G., France, Michael, Ferns, Gordon, Byrne, Chris D., Halcox, Julian, Datta, Dev, Capps, Nigel, Shoulders, Carol, Qureshi, Nadeem, Rees, Alan, Main, Linda, Cramb, Robert, Viljoen, Adie, Payne, Jules, Soran, Handrean

“…Lipoprotein(a), Lp(a), is a modified atherogenic low-density lipoprotein particle that contains apolipoprotein(a). Its levels are highly heritable and variable…”
Get full text

A guide for Gensini Score calculation by Rampidis, Georgios P., Benetos, Georgios, Benz, Dominik C., Giannopoulos, Andreas A., Buechel, Ronny R.

Get full text

The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation by Martínez, Gonzalo J., Celermajer, David S., Patel, Sanjay

“…Atherosclerosis is considered a chronic inflammatory disease of the arterial wall. Recently, compelling evidence has arisen for the role of monocytes and…”
Get full text

Vascular endothelium – Gatekeeper of vessel health by Cahill, Paul A, Redmond, Eileen M

“…Abstract The vascular endothelium is an interface between the blood stream and the vessel wall. Changes in this single cell layer of the artery wall are…”
Get full text

Saturated fatty acids trigger TLR4-mediated inflammatory response by Rocha, D.M, Caldas, A.P, Oliveira, L.L, Bressan, J, Hermsdorff, H.H

“…Abstract Toll-like receptors (TLR) mediate infection-induced inflammation and sterile inflammation by endogenous molecules. Among the TLR family, TLR4 is the…”
Get full text

Vascular oxidative stress, nitric oxide and atherosclerosis by Li, Huige, Horke, Sven, Förstermann, Ulrich

“…Abstract In the vascular wall, reactive oxygen species (ROS) are produced by several enzyme systems including NADPH oxidase, xanthine oxidase, uncoupled…”
Get full text

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) by Vallejo-Vaz, Antonio J., De Marco, Martina, Stevens, Christophe A.T., Akram, Asif, Freiberger, Tomas, Hovingh, G. Kees, Kastelein, John J.P., Mata, Pedro, Raal, Frederick J., Santos, Raul D., Soran, Handrean, Watts, Gerald F., Abifadel, Marianne, Aguilar-Salinas, Carlos A., Al-khnifsawi, Mutaz, AlKindi, Fahad A., Alnouri, Fahad, Alonso, Rodrigo, Al-Rasadi, Khalid, Al-Sarraf, Ahmad, Ashavaid, Tester F., Binder, Christoph J., Bogsrud, Martin P., Bourbon, Mafalda, Bruckert, Eric, Chlebus, Krzysztof, Corral, Pablo, Descamps, Olivier, Durst, Ronen, Ezhov, Marat, Fras, Zlatko, Genest, Jacques, Groselj, Urh, Harada-Shiba, Mariko, Kayikcioglu, Meral, Lalic, Katarina, Lam, Carolyn S.P., Latkovskis, Gustavs, Laufs, Ulrich, Liberopoulos, Evangelos, Lin, Jie, Maher, Vincent, Majano, Nelson, Marais, A. David, März, Winfried, Mirrakhimov, Erkin, Miserez, André R., Mitchenko, Olena, Nawawi, Hapizah M., Nordestgaard, Børge G., Paragh, György, Petrulioniene, Zaneta, Pojskic, Belma, Postadzhiyan, Arman, Reda, Ashraf, Reiner, Željko, Sadoh, Wilson E., Sahebkar, Amirhossein, Shehab, Abdullah, Shek, Aleksander B., Stoll, Mario, Su, Ta-Chen, Subramaniam, Tavintharan, Susekov, Andrey V., Symeonides, Phivos, Tilney, Myra, Tomlinson, Brian, Truong, Thanh-Huong, Tselepis, Alexandros D., Tybjærg-Hansen, Anne, Vázquez-Cárdenas, Alejandra, Viigimaa, Margus, Vohnout, Branislav, Widén, Elisabeth, Yamashita, Shizuya, Banach, Maciej, Gaita, Dan, Jiang, Lixin, Nilsson, Lennart, Santos, Lourdes E., Schunkert, Heribert, Tokgözoğlu, Lale, Car, Josip, Catapano, Alberico L., Ray, Kausik K.

“…Management of familial hypercholesterolaemia (FH) may vary across different settings due to factors related to population characteristics, practice, resources…”
Get full text

Sex differences in cardiovascular risk factors and disease prevention by Appelman, Yolande, van Rijn, Bas B, ten Haaf, Monique E, Boersma, Eric, Peters, Sanne A.E

“…Abstract Cardiovascular disease (CVD) has been seen as a men's disease for decades, however it is more common in women than in men. It is generally assumed in…”
Get full text

Cardioprotective microRNAs: Lessons from stem cell-derived exosomal microRNAs to treat cardiovascular disease by Moghaddam, Abbas Shapouri, Afshari, Jalil Tavakol, Esmaeili, Seyed-Alireza, Saburi, Ehsan, Joneidi, Zeinab, Momtazi-Borojeni, Amir Abbas

“…The stem cell-based therapy has emerged as a promising therapeutic strategy for treating cardiovascular ischemic diseases (CVIDs), such as myocardial…”
Get full text